Kathy Pritchard-Jones

发表

Renal Tumors in Children beyond the Age of 10 Years

Sergey Popov, Neil J. Sebire, Chris Jones, 2010 .

'Spread of Excellence' (Dissemination) Activities of the European Network of Excellence for Cancer Research in Children and Adolescents (ENCCA)

Kathy Pritchard-Jones, 2011 .

Lin28 sustains early renal progenitors and induces Wilms tumor

Hao Zhu, Kathy Pritchard-Jones, Neil Sebire, 2014, Genes & development.

miRNA Profiles as a Predictor of Chemoresponsiveness in Wilms’ Tumor Blastema

Sergey Popov, Norbert Graf, Kathy Pritchard-Jones, 2013, PloS one.

Malignant renal tumours incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project.

Eva Steliarova-Foucher, Norbert Graf, Ariana Znaor, 2006, European journal of cancer.

Learning what high quality compassionate care means for cancer patients and translating that into practice

Kathy Pritchard-Jones, Fiona McKenzie, Katherine Joel, 2014 .

The yin and yang of kidney development and Wilms’ tumors

Kathy Pritchard-Jones, Peter Hohenstein, K. Pritchard-Jones, 2015, Genes & development.

Frequent Long-Range Epigenetic Silencing of Protocadherin Gene Clusters on Chromosome 5q31 in Wilms' Tumor

Kathy Pritchard-Jones, Chris Jones, Raisa Vuononvirta, 2009, PLoS genetics.

Amplification and Overexpression of CACNA1E Correlates with Relapse in Favorable Histology Wilms' Tumors

Kathy Pritchard-Jones, Chris Jones, Boo Messahel, 2006, Clinical Cancer Research.

Biology and treatment of renal tumours in childhood.

Kathy Pritchard-Jones, Jesper Brok, K. Pritchard-Jones, 2016, European journal of cancer.

Improving recruitment to clinical trials for cancer in childhood.

Maria Grazia Valsecchi, Mary Dixon-Woods, Kathy Pritchard-Jones, 2008, The Lancet. Oncology.

Sustaining innovation and improvement in the treatment of childhood cancer: lessons from high-income countries.

Rob Pieters, Eva Steliarova-Foucher, Kathy Pritchard-Jones, 2013, The Lancet. Oncology.

Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors.

Eckart Meese, Andreas Keller, Roland Eils, 2015, Cancer cell.

Stratification of Wilms tumor by genetic and epigenetic analysis

Nazneen Rahman, Neil J. Sebire, Kathy Pritchard-Jones, 2012, Oncotarget.

PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification.

Mauro Delorenzi, Jean-Paul Concordet, Olivier Delattre, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.